Science Explorer Interactive view Map
Company · Solna · Sweden

Bristol-Myers Squibb (Sweden)

In research, Bristol-Myers Squibb (Sweden) stands highest in Medicine (#4,150 of 17,978 worldwide), Health Sciences (#5,538 of 20,462 worldwide) and Life Sciences (#4,432 of 14,347 worldwide), over all time.

bms.com/seROR OpenAlex
World rank, 2022–2025
#13,547
of 28,054 · #7,506 all time
Rank in Sweden
#66
of 125
Research works
623
▼ 8% vs 2013–17
Citations
27k
42.9 per fractional work
Top-10% rate
14.7%
record average 16.5%
Open access
39%
world 28%

What is Bristol-Myers Squibb (Sweden) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #4,150 of 17,978 26.2%299
Health SciencesDomain #5,538 of 20,462 26.3%308
Life SciencesDomain #4,432 of 14,347 26.9%203
Biochemistry, Genetics and Molecular BiologyField #5,068 of 7,814 24.7%135

Each strip is that field’s whole ranked pool, with the notch where Bristol-Myers Squibb (Sweden) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.08× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.42× its world share, 18 worksBiochemistry, Geneti…Immunology and Microbiology: 4.85× its world share, 5 worksImmunology and Micro…Neuroscience: 0.74× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.49× its world share, 2 worksPharmacology, Toxico…Chemistry: 2.91× its world share, 5 worksChemistryComputer Science: 0.33× its world share, 3 worksComputer ScienceEarth and Planetary Sciences: 0.08× its world share, 0 worksEarth and Planetary …Engineering: 0.08× its world share, 1 worksEngineeringEnvironmental Science: 0.08× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials ScienceMathematics: 2.07× its world share, 2 worksMathematicsPhysics and Astronomy: 0.10× its world share, 0 worksPhysics and AstronomyDentistry: 0.17× its world share, 0 worksDentistryHealth Professions: 0.04× its world share, 0 worksHealth ProfessionsMedicine: 2.83× its world share, 55 worksMedicineNursing: 0.70× its world share, 0 worksNursingVeterinary: 0.68× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.21× its world share, 1 worksBusiness, Management…Decision Sciences: 0.98× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 1.26× its world share, 3 worksEconomics, Econometr…Psychology: 0.29× its world share, 1 worksPsychologySocial Sciences: 0.08× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.5×. Every wedge is a field page.

Which keywords describe research at Bristol-Myers Squibb (Sweden)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Microenvironment, Lymphoma, Cancer Immunotherapy, Prognostic Factors, Tumor Regression, Immune Checkpoint Blockade and PD-1 and PD-L1.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy7▲ 10×14 topics
  2. Tumor Microenvironment6▲ 13×7 topics
  3. Inflammation5▲ 2.5×33 topics
  4. Lymphoma5▲ 30×4 topics
  5. Cancer Immunotherapy5▲ 30×3 topics
  6. Prognostic Factors4▲ 9.9×8 topics
  7. Tumor Regression4▲ 39×2 topics
  8. Chemotherapy4▲ 5.6×13 topics
  9. Immune Checkpoint Blockade4▲ 36×1 topic
  10. Leukemia4▲ 46×2 topics
  11. PD-1 and PD-L14▲ 36×1 topic
  12. CAR T Cells4▲ 52×1 topic
  13. Chimeric Antigen Receptor4▲ 52×1 topic
  14. Targeted Therapy4▲ 16×4 topics
  15. Clinical Trials4▲ 5.3×8 topics
  16. Treatment4▲ 2.9×16 topics
  17. Transcriptional Regulation4▲ 22×6 topics
  18. Cancer Therapy3▲ 5.9×12 topics
  19. TGF-ß3▲ 21×4 topics
  20. Minimal Residual Disease3▲ 45×2 topics
  21. Proteasome Inhibitors3▲ 42×2 topics
  22. Biomarkers3▲ 4.1×9 topics
  23. Diagnosis Criteria3▲ 75×1 topic
  24. International Myeloma Working Group3▲ 75×1 topic
  25. Staging System3▲ 44×2 topics
  26. Drug Discovery3▲ 12×7 topics
  27. Fibrosis3▲ 14×5 topics
  28. Treatment Guidelines2▲ 11×3 topics
  29. BET Bromodomains2▲ 84×1 topic
  30. PROTACs2▲ 84×1 topic
  31. Autoantibodies2▲ 9.6×5 topics
  32. Genomic Profiling2▲ 22×2 topics
  33. Pharmacokinetics2▲ 8.5×4 topics
  34. Signal Transduction2▲ 16×3 topics
  35. ALK Inhibitors2▲ 34×1 topic
  36. AML2▲ 42×1 topic
  37. Acute Myeloid Leukemia2▲ 42×1 topic
  38. EGFR Mutations2▲ 34×1 topic
  39. Hematopoietic Stem Cells2▲ 24×2 topics
  40. Epithelial-Mesenchymal Transition2▲ 20×3 topics

Which research topics does Bristol-Myers Squibb (Sweden) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Multiple Myeloma Research and Treatments and Protein Degradation and Inhibitors.

Cancer Immunotherapy and Biomarkers: 4 fractional worksCAR-T cell therapy research: 4 fractional worksMultiple Myeloma Researc…3Multiple Myeloma Research and Treatments: 3 fractional worksProtein Degradation and …2Protein Degradation and Inhibitors: 2 fractional worksLung Cancer Treatments and Mutations: 2 fractional worksAcute Myeloid Leukemia Research: 2 fractional worksMyeloproliferative Neopl…2Myeloproliferative Neoplasms: Diagnosis and Treatment: 2 fractional worksInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 2 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksPharmacogenetics and Drug Metabolism: 1 fractional works
OncologyHematologyMolecular BiologyPulmonary and Respiratory Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 4 works
  2. 2 CAR-T cell therapy research Oncology 4 works
  3. 3 Multiple Myeloma Research and Treatments Hematology 3 works
  4. 4 Protein Degradation and Inhibitors Molecular Biology 2 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  6. 6 Acute Myeloid Leukemia Research Hematology 2 works
  7. 7 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
  8. 8 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 2 works
  9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  10. 10 Pharmacogenetics and Drug Metabolism Pharmacology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.1%not open60.9%

World: 28% of research is openly available.

with international co-authors83.7%domestic only16.3%

World: 19% is written across borders.

How has Bristol-Myers Squibb (Sweden)'s research output changed?

Output in 2018–2022 was 8% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Solna

All research institutions in Solna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.